101 results
S-1
EX-10.16
GOSS
Gossamer Bio Inc
21 Dec 18
IPO registration
4:39pm
and refer to the Existing Premises as expanded by the Expansion Space.
3.Vivarium. Sublessee desires access to the Vivarium as soon as reasonably … insurance will not result in any rent credit).
4.Early Access. Sublessor will allow Sublessee access to the Remainder Space (except for Suite 150) from
DRS
EX-10.12
GOSS
Gossamer Bio Inc
11 Oct 18
Draft registration statement
12:00am
and refer to the Existing Premises as expanded by the Expansion Space.
3.Vivarium. Sublessee desires access to the Vivarium as soon as reasonably … insurance will not result in any rent credit).
4.Early Access. Sublessor will allow Sublessee access to the Remainder Space (except for Suite 150) from
8-K
EX-99.1
GOSS
Gossamer Bio Inc
14 May 19
Gossamer Bio Announces First Quarter 2019 Financial Results
7:31am
-year $150 million senior debt facility, with $30 million funded at closing, and access to the remaining $120 million subject to the achievement … , cash equivalents and marketable securities, and access to its debt facility will be sufficient to fund its operating and capital expenditures
8-K
EX-99.1
GOSS
Gossamer Bio Inc
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
of the facility will be funded at closing, with the ability to access the remaining $120 million, subject to the achievement of certain clinical development … milestones and other customary conditions. The facility provides the company with access to capital for general corporate purposes and to support
8-K
EX-99.1
GOSS
Gossamer Bio Inc
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
and general corporate purposes. The proceeds from this financing, combined with current cash, cash equivalents and marketable securities, and access to its … expenditures with current cash, cash equivalents and marketable securities, and access to its debt facility. Such forward-looking statements involve substantial
8-K
EX-99.1
fr135mgbij z0
3 Nov 22
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
4:00pm
8-K
EX-99.1
z8r8msp27kv
12 Nov 19
Gossamer Bio Announces Third Quarter 2019 Financial Results
4:10pm
8-K
EX-99.1
0t4 nyuwq
9 Aug 22
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update
8:08am
8-K
EX-99.1
tzi381t au
8 Aug 19
Gossamer Bio Announces Second Quarter 2019 Financial Results
4:10pm
8-K
EX-99.1
n8z1u63skfn
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
DRS
EX-10.11
prmiv5dh34g dmd0
11 Oct 18
Draft registration statement
12:00am
DEFA14A
05hu q38y
27 Apr 20
Additional proxy soliciting materials
4:20pm
S-1
EX-10.15
hb8sykokmn3sihrr1g5k
21 Dec 18
IPO registration
4:39pm
DEFA14A
13ae32 ryuj8t
30 Apr 19
Additional proxy soliciting materials
4:15pm
8-K
mlg42c4t
2 Jul 20
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.1
y2zh vbt9ddfl5elvhhj
8 Nov 21
Gossamer Bio Announces Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm